Ads
related to: drug companies- For HCPs
Find Healthcare Professional
Resources & Information
- $0 Co-Pay
Learn How You Can Save on cGVHD
Treatment w/ our Co-Pay Program.
- For Chronic GVHD
Discover an Option That
May Help with Scarring and Swelling
- FAQs and Resources
Find Resources and Answers
to Frequently Asked Questions.
- For HCPs
grandriverasepticmfg.com has been visited by 10K+ users in the past month
Search results
Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?
LA Times via AOL· 5 hours agoSchool of Medicine. “They’re going to have to deal with this.” No matter how expensive a drug, it's...
Wolfe Research lifts Insmed stock PT by $12 on strong drug prospects By Investing.com
Investing.com· 2 hours agoThe adjustment follows promising data regarding Insmed's brensocatib, a drug candidate for the...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
CNBC· 3 hours agoIt agreed to pay $1.3 billion in cash and another $1.7 billion in future milestone-based payments...
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral...
St. Joseph News-Press· 4 hours ago(NYSE American: NNVC ) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral...
NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward...
Digital Journal· 2 hours agoNurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative ...
AXIM Biotechnologies Receives Medical Device Manufacturing License
Digital Journal· 2 hours agoPRESS RELEASE Published May 29, 2024 NewMediaWire State of California Department of Public Heath Food and Drug Branch Issues the Company a License for Manufacturing ...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Reuters via Yahoo News· 13 hours agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to...
AXIM Biotechnologies Receives Medical Device Manufacturing License
NewMediaWire via Yahoo Finance· 2 hours agoState of California Department of Public Heath Food and Drug Branch Issues the Company a License for...
Highmark Members Save Significant Money on Outpatient Cancer Drug Available through CivicaScript
PRWeb· 3 hours ago"In 2020, Highmark teamed with the Blue Cross Blue Shield Association and other leading Blues health plans from across the U.S. to found CivicaScript, a nonprofit generic drug
Catalent stockholders approve buyout by Novo Holdings
AOL· 1 hour agoIn February, Novo Holdings had agreed to buy the contract drug manufacturer for $16.5 billion to boost the output of its blockbuster obesity drug Wegovy ...